RNAi screening of the kinome with cytarabine in leukemias

To identify rational therapeutic combinations with cytarabine (Ara-C), we developed a high-throughput, small-interference RNA (siRNA) platform for myeloid leukemia cells. Of 572 kinases individually silenced in combination with Ara-C, silencing of 10 (1.7%) and 8 (1.4%) kinases strongly increased Ar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Tibes, Raoul, Bogenberger, James M., Chaudhuri, Leena, Hagelstrom, R. Tanner, Chow, Donald, Buechel, Megan E., Gonzales, Irma M., Demuth, Tim, Slack, James, Mesa, Ruben A., Braggio, Esteban, Yin, Hongwei H., Arora, Shilpi, Azorsa, David O.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2012
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8221104/
https://ncbi.nlm.nih.gov/pubmed/22267604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-07-367557
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados